ArticleGigaScience2024
demuxSNP: supervised demultiplexing single-cell RNA sequencing using cell hashing and SNPs.
Article in GigaScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- fastdemux: Robust SNP-based demultiplexing of single-cell population genomics data.bioRxiv : the preprint server for biology · 2026Article
- Systematic benchmark of single-cell hashtag demultiplexing approaches reveals robust performance of a clustering-based method.Briefings in functional genomics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundMultiplexing single-cell RNA sequencing experiments reduces sequencing cost and facilitates larger-scale studies. However, factors such as cell hashing quality and class size imbalance impact demultiplexing algorithm performance, reducing cost-effectiveness.
findingsWe propose a supervised algorithm, demuxSNP, which leverages both cell hashing and genetic variation between individuals (single-nucletotide polymorphisms [SNPs]). demuxSNP addresses fundamental limitations in demultiplexing methods that use only one data modality. Some cells may be confidently demultiplexed using probabilistic hashing methods. demuxSNP uses these data to infer the genotype of singlet and doublet clusters and predict on cells assigned as negative, uncertain, or doublet using a nearest-neighbor approach adapted for missing data.We benchmarked demuxSNP against hashing, genotype-free SNP and hybrid methods on simulated and real data from renal cell cancer. demuxSNP outperformed standalone hashing methods on low-quality hashing data benchmark, improved overall classification accuracy, and allowed more high RNA quality cells to be recovered. Through varying simulated doublet rates, we showed that genotype-free SNP and hybrid methods that leverage them were impacted by class size imbalance and doublet rate. demuxSNP's supervised approach was more robust to doublet rate in experiments with class size imbalance.
conclusionsdemuxSNP uses hashing and SNP data to demultiplex datasets with low hashing quality where biological samples are genetically distinct. Unassigned or negative cells with high RNA quality are recovered, making more cells available for analysis. Data simulation and benchmarking pipelines as well as processed benchmarking data for 5-50% doublets are publicly available. demuxSNP is available as an R/Bioconductor package (https://doi.org/doi:10.18129/B9.bioc.demuxSNP).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.